Efficiency and delta strain (not delta plus!)

We found an absolute reduction of one dose vaccine effectiveness against symptomatic disease with the B.1.617.2 variant of approximately 20% when compared to the B.1.1.7 variant. However, reductions in vaccine effectiveness after two doses were very small. This was the case for both the BNT162b2 and ChAdOx1 vaccines. Using a TNCC analysis, estimated vaccine effectiveness against symptomatic disease with B.1.617.2 for a single dose of either vaccine is approximately 33%, for two doses of BNT162b2 is approximately 88% and for two doses of ChAdOx1 is approximately 60%.

Overall, we found high levels of vaccine effectiveness against symptomatic disease after two doses. These estimates were only modestly lower than vaccine effectiveness against the B.1.1.7 variant. It is likely that vaccine effectiveness against more severe disease outcomes will be greater. Our finding of reduced effectiveness after dose 1, would support maximising vaccine uptake with two doses among vulnerable groups in the context of circulation of B.1.617.2.

https://www.medrxiv.org/content/10.1101/2021.05.22.21257658v1.full

Dunno if you want to wait for Novavax, but it probably is a safer technology. But we won't know until it has been used for a while, so there's a real risk.

SOME VACCINES HAVE GRAPHENE OXIDE. i still on it, investigating more about, but some videos have emerged talking about a vaccine that was put to an electronic microscope and the results show structures similar to Graphene inside it really similar.

mRNA vaccine efficacy is VERY dubious, IHMO. Check this out...

UK

According to latest data from PHE, a single dose of vaccine reduces a person's chances of catching coronavirus and needing hospital treatment by about 75%, even with Delta circulating in the UK.

And among people who had received the recommended two doses, the chances of catching and being hospitalised by coronavirus was reduced by more than 90%.

Of 806 people infected with the Delta variant who ended up hospital in England between 1 February and 14 June 2021:

• 527 (65%) people were unvaccinated
• 135 (17%) were more than 21 days after their first dose of vaccine
• 84 (10%) were more than 14 days after their second dose

As of 14 June, there have been 73 deaths in England of people who were confirmed as having the Delta variant and who died within 28 days of a positive test, and of these:

• 34 (47%) were unvaccinated
• 10 (14%) were more than 21 days after their first dose of vaccine
• 26 (36%) were more than 14 days after their second dose

@arum

I have never heard of our bodies producing a protein that would be attacked by our own antibodies (which does not mean that it is not possible). Any sources for this happening?

I had some older posts in main topic, also look for preprints and other sources of scientific papers.

Thing is that science do not fully and totally understand how antibodies work and how they are formed. Why they use one part of protein and not another. And for different people it can be different parts.

Antibodies tests go around this by feeding you long enough proteins so different antibodies will attack it anyway.

you are suggesting that the spike proteins created as a reaction to the mRNA from the vaccine will cause cell damage

They don't damage the cell - they prevent proper function of our own proteins that are similar to spike protein of COVID. Look at this as you come home and in the lock you have half turned and broken key, so you can't open the lock now.

I am however willing to trust my own father and his partner who are a medical doctors and seems pretty comfortable with the vaccines.

Don't be. As complexity of real biology is very big. So most medic workers just translate information that they had been told. So, it does not make it any more credible.

@arum

Your fact check thing is wrong, as it want to redirect attention.

We have two problems with any COVID vaccines.

First problem - spike protein produced go across the body and sticks into receptive cells, preventing normal functioning of very complex processes.

Second problem - antibodies made also can attack our own proteins that have similar or same parts (and they have such). Issue with this si that process is very slow, you won't die from this. But main impact goes into small blood vessels and lungs. They slowly and steadily loose the needed functions as affected proteins play vital function in expansion and contraction of them.

Thing that COVID and vaccine authors did is called forcing card trick. No matter that you choose - not being vaccinating and catch virus or get vaccine - it is both not good choices for you and it is both good choices for authors of all this, as it seems. And they want to keep two of this alternatives.

This also fully explain huge informational attacks, brutal and open, on anything that can cure COVID or easy it and that is not vaccine.

Quite bad news about mRNA vaccines

We made a big mistake, "- so Bayram Bridle, a viral immunologist and assistant professor at the University of Guelph in Ontario, described the results of vaccination studies with new mRNA vaccines against coronavirus, writes Children's Health Defense.

Research by a team of scientists shows that the vaccine spike protein can travel from the injection site and accumulate in organs and tissues, including the spleen, bone marrow, liver, adrenal glands, and ovaries. Previously, it was assumed that new vaccines would behave in the same way as traditional vaccines.

“We thought the spike protein was an excellent target antigen, but we didn't know that the spike protein itself was a toxin and a pathogenic protein. So when we vaccinate people, we inadvertently inject the toxin into them,” Bridle said.

Together with a group of scientists from other countries, he submitted a request for information from a Japanese regulatory agency to access biodistribution studies after vaccination with the Pfizer vaccine.

According to him, this is the first such study. And it shows that the drug does not remain in the muscles of the shoulder, but is dispersed throughout the body.

It has also been found that vaccination leads to problems with the cardiovascular system. The immunologist explained the mechanism of this effect, which was previously discovered empirically in many countries. It has been established that the spike protein is almost entirely responsible for the damage to the cardiovascular system.

On the eve of the US Centers for Disease Control and Prevention said that new gene vaccines lead to massive increase of heart diseases.

Immunology veteran J. Bart Klassen has published an article in the peer-reviewed scientific journal Microbiology & Infectious Diseases. According to the results, new vaccines can have a terrible delayed effect, which will manifest itself only years later and undermine the health of many people.

Seychelles, which has fully vaccinated more than 60% of the population from Covid-19, is returning restrictions amid rising numbers of new cases. In the archipelago, with a population of almost 100,000, about 500 new cases were reported in the three days prior to May 1, and there are currently about 1,000 active cases (sick).

A third of active cases are associated with people who received two doses of the vaccine, according to the country's news agency. Others either received a single dose or were not vaccinated.

By mid-April, about 60% of the vaccine doses used in the country were from Sinopharm, with the rest from Indian-made AstraZeneca.

...and then there's this:
https://www.bitchute.com/video/1f9M4JpMOXTN/

Another interesting video on Vitamin D, COVID, and vaccinations by Dr. Ryan Cole:

BCG vaccines

A large scale community-based double blind randomized controlled trial was carried out in Chingleput district of south India to evaluate the protective effect of BCG against bacillary forms of pulmonary tuberculosis. From among 366,625 individuals registered, 281,161 persons were vaccinated with BCG or placebo by random allocation. Two strains of BCG were used, the French and Danish, with a high dose (0.1 mg/0.1 ml) and a low dose (0.01 mg/0.1 ml) in each strain. The entire population was followed up for 15 years by means of resurveys every 30 months, and selective follow up every 10 months and continuous passive case finding. There were 560 cases (189, 191 and 180 from the high dose, low dose and placebo groups respectively) arising over 15 years, among 109,873 persons who were tuberculin negative and had a normal chest X-ray at intake. This represents a small fraction of the total incidence of 2.6 per 1000 person-years most of which came from those who were initially tuberculin positive. The incidence rates in the three "vaccination" groups were similar confirming the complete lack of protective efficacy, seen at the end of 7 1/2 years.

https://pubmed.ncbi.nlm.nih.gov/10573656/